Korro Bio, Inc. (KRRO) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 10 Buy, 2 Hold.
The consensus price target is $20.29 (low: $10.00, high: $30.00), representing an upside of 48.3% from the current price $13.68.
Analysts estimate Earnings Per Share (EPS) of $-9.25 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-9.37 vs est $-9.25 (missed -1.3%). 2025: actual $-12.48 vs est $-9.03 (missed -38.2%). Analyst accuracy: 86%.
KRRO Stock — 12-Month Price Forecast
$20.29
▲ +48.32% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Korro Bio, Inc., the average price target is $20.29, with a high forecast of $30.00, and a low forecast of $10.00.
The average price target represents a +48.32% change from the last price of $13.68.
Highest Price Target
$30.00
Average Price Target
$20.29
Lowest Price Target
$10.00
KRRO Analyst Ratings
Buy
Based on 12 analysts giving stock ratings to Korro Bio, Inc. in the past 3 months
EPS Estimates — KRRO
86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$9.37
vs Est –$9.25
▼ 1.3% off
2025
Actual –$12.48
vs Est –$9.03
▼ 27.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — KRRO
5%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.002B
vs Est $0.006B
▼ 176.6% off
2025
Actual $0.006B
vs Est $0.006B
▲ 13.6% off
Revenue Trend
Strong revenue growth over the period shown. Analysts expect stable revenue going forward.
